The Effect of Phonomyography Prototype for Intraoperative Neuromuscular Monitoring: A Preliminary Study

• Published in: Bioengineering (Basel) Vol. 11; no. 5; p. 486
• Main Authors: Dong, Yanjie, Guo, Weichao, Yang, Yi, Li, Qian
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01-05-2024
• Subjects: acceleromyography; Anesthesia; Blood pressure; Calibration; Clinical medicine; Clinical practice guidelines; Complications; Complications and side effects; Dosage and administration; Feasibility studies; General anesthesia; Health aspects; Intubation; Lung diseases; Monitoring; Muscle contraction; muscle sound; Neuromuscular blocking agents; Neuromuscular diseases; neuromuscular monitoring; Patients; Pharmacodynamics; phonomyography; Physiological aspects; Prevention; Prototypes; Risk factors; Statistics; Surgery; China; Ireland; phonomyography; neuromuscular monitoring; acceleromyography; muscle sound
• ISSN: 2306-5354; 2306-5354
• DOI: 10.3390/bioengineering11050486

Quantitative neuromuscular monitoring, as extolled by clinical guidelines, is advocated to circumvent the complications associated with neuromuscular blockers (NMBs), such as residual neuromuscular block (rNMB). Nonetheless, the worldwide utilization of such methods remains undesirable. Phonomyography (PMG) boasts the advantages of convenience, stability, and multi-muscle recording which may be a promising monitoring method. The purpose of this preliminary study is conducting a feasibility analysis and an effectiveness evaluation of a PMG prototype under general anesthesia. A prospective observational preliminary study was conducted. Twenty-five adults who had undergone none-cardiac elective surgery were enrolled. The PMG prototype and TOF-Watch SX simultaneously recorded the pharmacodynamic properties of single bolus rocuronium at the ipsilateral adductor pollicis for each patient. For the primary outcome, the time duration to 0.9 TOF ratio of the two devices reached no statistical significance (
> 0.05). For secondary outcomes, the multi-temporal neuromuscular-monitoring measurements between the two devices also reached no statistical significance (
> 0.05). What is more, both the Spearman's and Pearson's correlation tests revealed a strong correlation across all monitoring periods between the PMG prototype and TOF-Watch SX. Additionally, Bland-Altman plots demonstrated a good agreement between the two devices. Thus, the PMG prototype was a feasible, secure, and effective neuromuscular-monitoring technique during general anesthesia and was interchangeable with TOF-Watch SX.